Symeres is the leading mid-sized trans-Atlantic contract research organization for your drug discovery and development needs. With over 600 scientists at several locations (Groningen, Nijmegen, Weert and Oss in the Netherlands, Prague in the Czech Republic, Boston and Princeton in USA and Oulu in Finland) Symeres offers best-in-class solutions for drug discovery and drug development for small molecules and beyond.
The services span from early-stage hit finding all the way to the delivery of your early clinical drug substance API. At Symeres, deep scientific knowledge base is blend with creativity to deliver the quality results your project needs.
Symeres delivers best-in-class chemistry solutions for drug discovery and early drug development. The discovery services span from early stage hit finding to clinical candidate identification. Symeres also partners with leading CROs for specific biological platforms, offering an integrated solution to your drug discovery needs.
Symeres offers high-quality services for synthetic chemistry and preparation of research compounds, including extensive experience in metabolite synthesis. The synthesis services span from route design to milligram- and kilogram-scale supply of materials, for any application where complex molecules matter.
With two separate non-GMP and cGMP supporting business units, Symeres is able to offer chemistry solutions for early drug development. The services include route scouting, risk assessments, catalyst screens, solid-state chemistry, and early safety studies, to ensure that the route chosen for clinical supply will be robust, reliable, and ultimately scalable. Symeres delivers your early clinical drug substance API (phase I/II).
More information about how we can support with integrated drug discovery services is available on Symeres website.